ALB and Hepatitis: This is in contrast with the work on those treated for mycobacterial infection with rifampicin, where alcohol excess, low BMI, low serum albumin, age and gender have been suggested as predisposing factors.10, 11, 23, 24 Multi‐centre studies will be needed to further investigate potential risk factors for rifampicin‐induced hepatitis in the context of liver disease.